• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Introduction to Tert-Butyl 3-(4-(trifluoromethyl)phenoxy)-3-phenylpropylcarbamate (CAS No. 257892-44-7)

Tert-Butyl 3-(4-(trifluoromethylphenoxy))-3-phenylpropylcarbamate is a sophisticated organic compound that has garnered significant attention in the field of pharmaceutical chemistry and drug discovery. This compound, identified by its Chemical Abstracts Service (CAS) number 257892-44-7, represents a class of molecules that exhibit promising biological activities. Its unique structural features, including the presence of a trifluoromethyl group and a phenylpropyl moiety, make it a valuable candidate for further investigation in medicinal chemistry.

The trifluoromethyl group is a well-known pharmacophore that enhances the metabolic stability and lipophilicity of molecules, making them more suitable for oral administration. This group is frequently incorporated into drug candidates to improve their pharmacokinetic properties. In contrast, the phenylpropyl chain contributes to the compound's solubility and binding affinity to biological targets. The carbamate functional group at the terminal position adds another layer of versatility, allowing for further derivatization and optimization.

In recent years, there has been a surge in research focused on developing novel therapeutic agents with enhanced efficacy and reduced side effects. Tert-butyl 3-(4-(trifluoromethylphenoxy))-3-phenylpropylcarbamate has emerged as a compound of interest due to its potential applications in various therapeutic areas. For instance, studies have suggested that this molecule may exhibit inhibitory effects on certain enzymes and receptors involved in inflammatory pathways. These findings are particularly relevant given the increasing prevalence of chronic inflammatory diseases worldwide.

The structural design of Tert-butyl 3-(4-(trifluoromethylphenoxy))-3-phenylpropylcarbamate aligns with current trends in drug development, which emphasize the importance of molecular diversity and target specificity. The combination of the trifluoromethyl group and the phenylpropyl moiety creates a scaffold that can be fine-tuned to achieve optimal interactions with biological targets. This approach has been successfully applied in the development of several FDA-approved drugs, underscoring the importance of rational drug design.

In addition to its potential therapeutic applications, Tert-butyl 3-(4-(trifluoromethylphenoxy))-3-phenylpropylcarbamate has also attracted attention for its synthetic utility. The presence of multiple functional groups provides chemists with numerous opportunities for structural modification. This flexibility allows researchers to explore different chemical spaces and identify novel analogs with improved properties. Such explorations are crucial for advancing drug discovery efforts and overcoming challenges associated with resistance and toxicity.

The latest research in this area highlights the compound's potential as an intermediate in the synthesis of more complex molecules. For example, studies have demonstrated its utility in generating derivatives with enhanced binding affinity or altered pharmacokinetic profiles. These findings underscore the importance of Tert-butyl 3-(4-(trifluoromethylphenoxy))-3-phenylpropylcarbamate as a building block in medicinal chemistry. By leveraging its structural features, researchers can develop innovative strategies for creating next-generation therapeutics.

The compound's relevance extends beyond academic research, as it holds promise for industrial applications as well. Pharmaceutical companies are increasingly investing in high-throughput screening technologies to identify promising candidates for further development. Tert-butyl 3-(4-(trifluoromethylphenoxy))-3-phenylpropylcarbamate, with its unique combination of structural features, is well-positioned to emerge as a key player in these efforts.

In conclusion, Tert-butyl 3-(4-(trifluoromethylphenoxy))-3-phenylpropylcarbamate(CAS No. 257892-44-7) represents a significant advancement in pharmaceutical chemistry. Its structural design, characterized by the presence of a trifluoromethyl group and a phenylpropyl moiety, makes it a versatile and valuable compound for drug discovery efforts. The latest research highlights its potential as an intermediate in synthesizing novel therapeutics and underscores its importance in addressing current challenges in medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)